Walleye Capital’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
+36,418
| New | +$209K | ﹤0.01% | 1367 |
|
|
2025
Q1 | – | Sell |
-44,516
| Closed | -$419K | – | 2004 |
|
|
2024
Q4 | $419K | Sell |
44,516
-359,725
| -89% | -$3.39M | ﹤0.01% | 1232 |
|
|
2024
Q3 | $4.32M | Buy |
404,241
+392,630
| +3,382% | +$4.19M | 0.01% | 484 |
|
|
2024
Q2 | $115K | Sell |
11,611
-10,733
| -48% | -$106K | ﹤0.01% | 2020 |
|
|
2024
Q1 | $263K | Buy |
+22,344
| New | +$263K | ﹤0.01% | 1698 |
|
|
2023
Q4 | – | Sell |
-172,169
| Closed | -$2.09M | – | 2456 |
|
|
2023
Q3 | $2.09M | Buy |
+172,169
| New | +$2.09M | 0.01% | 641 |
|
|
2022
Q1 | – | Sell |
-14,051
| Closed | -$162K | – | 2306 |
|
|
2021
Q4 | $162K | Buy |
+14,051
| New | +$162K | 0.01% | 1495 |
|
|
2021
Q2 | – | Sell |
-33,600
| Closed | -$332 | – | 1376 |
|
|
2021
Q1 | $332 | Buy |
+33,600
| New | +$332 | 0.02% | 707 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 676 |
|
|
2019
Q2 | – | Sell |
-414
| Closed | -$6K | – | 645 |
|
|
2019
Q1 | $6K | Buy |
+414
| New | +$6K | ﹤0.01% | 346 |
|